Clinical cardiovascular pharmacology in Anesthesiology _ Pharmacology of myocardial protection
DOI:
https://doi.org/10.25751/rspa.8844Keywords:
Pharmacology of myocardial protection, adrenergic beta receptors blockers, statins, volatile anesthetics, angiotensin-converting enzyme inhibitors, calcium channel blockers.Abstract
An increasingly older population in developed countries originated a high prevalence of patients taking cardiovascular medication. Anesthesiologists must know indications and therapeutic interactions between this drugs and anesthetic agents. Available evidence let’s talk about the pharmacology of myocardial protection. The current guidelines seem to follow positive outcome studies concerning what drugs should be introduced, continued or suspended throughout the perioperative period.Downloads
Download data is not yet available.
Downloads
Published
2016-03-22
How to Cite
Amaral, C. (2016). Clinical cardiovascular pharmacology in Anesthesiology _ Pharmacology of myocardial protection. Journal of the Portuguese Society of Anesthesiology, 21(1), 8–15. https://doi.org/10.25751/rspa.8844
Issue
Section
Narrative Reviews
License
Articles are freely available to be read, downloaded and shared from the time of publication.
The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.
Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).
After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.
